BIO-key International (BKYI) Q2 2024 earnings summary

Executive summary

• Q2 2024 revenue declined to $1.0–$1.14 million from $1.9 million in Q2 2023, mainly due to delayed software license contracts and lower services revenue, with ongoing net losses but improved gross margins and cost reductions.

• PortalGuard IAM franchise and Passkey:YOU product saw notable deployments and initial strong customer interest, especially in healthcare and public sector segments.

• Solutions are now available on AWS Marketplace, expected to drive global reach and recurring revenues.

• Ongoing challenges include delayed international projects, loss of major customers, and the need for additional financing to sustain operations.

• Recent financing activities included a $2.36 million senior secured promissory note to support working capital.

Financial highlights

• Q2 2024 revenue: $1.0–$1.14 million, down from $1.9 million in Q2 2023; six-month revenue: $3.3 million, down year-over-year.

• Gross margin improved to 77% in Q2 2024 from 16.7–69% in Q2 2023, driven by higher-margin services and absence of a $1 million hardware reserve.

• Net loss improved to $1.7 million ($1.00/share) in Q2 2024 from $2.6 million ($4.71/share) in Q2 2023; six-month net loss reduced to $2.2 million from $4.3 million.

• Operating expenses reduced by $168,000–$200,000 year-over-year, mainly in admin, sales, and marketing.

• Cash and equivalents at June 30, 2024: $1.26–$1.3 million, up from $511,400 at December 31, 2023.

Outlook and guidance

• Management targets sequential and year-over-year revenue growth for full year 2024, with expectations for a stronger second half and ongoing focus on profitability and positive cash flow.

• Several large projects in RFP and proof-of-concept stages could benefit H2 2024 results; AWS Marketplace launch expected to generate revenue starting in 2024.

• Service revenue expected to remain at current lower levels due to loss of a large customer; additional financing likely required within twelve months.

• Ongoing focus on cost control and strategic opportunities to leverage core assets and monetize reserved inventory.